共 83 条
- [1] [Anonymous], 2016, PFLUGERS ARCH EUR J, V468, P1299
- [5] Rate of CRL4CRBN substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4 [J]. BLOOD CANCER JOURNAL, 2015, 5 : e354 - e354
- [9] CARTER CJ, 1981, LANCET, V1, P1427